scholarly article | Q13442814 |
P356 | DOI | 10.1017/S0007114516003743 |
P698 | PubMed publication ID | 27821214 |
P50 | author | Mette Olsen | Q45324664 |
Markos Tesfaye | Q45324680 | ||
Pernille Kæstel | Q51436360 | ||
Henrik Friis | Q85926034 | ||
Ole Kirk | Q102213445 | ||
Henrik Krarup | Q42767014 | ||
Christian Mølgaard | Q43062546 | ||
P2093 | author name string | Alemseged Abdissa | |
Christian Ritz | |||
Daniel Yilma | |||
Kim F Michaelsen | |||
Tsinuel Girma | |||
Åse B Andersen | |||
P2860 | cites work | Cross-Sectional and Longitudinal Evaluation of Body Composition in Men With HIV Infection | Q46103723 |
Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons | Q46174328 | ||
Vitamin D insufficiency in a sunshine-sufficient area: southern Ethiopia | Q46590069 | ||
Relative influences of sex, race, environment, and HIV infection on body composition in adults | Q46746167 | ||
Food insecurity among volunteer AIDS caregivers in Addis Ababa, Ethiopia was highly prevalent but buffered from the 2008 food crisis | Q46917291 | ||
Weight and body composition in a cohort of HIV-positive men and women. | Q47207979 | ||
The effect of antiretrovirals on vitamin D. | Q54443730 | ||
Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian Cohort | Q56334704 | ||
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study | Q57877133 | ||
Oral vitamin D supplementation has a lower bioavailability and reduces hypersecretion of parathyroid hormone and insulin resistance in obese Chinese males | Q64126927 | ||
Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population | Q64129102 | ||
Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy | Q83227826 | ||
Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? | Q83632365 | ||
The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity | Q28483688 | ||
Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users | Q28538127 | ||
Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia | Q33618988 | ||
25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings | Q34076892 | ||
Effect of rifampicin and isoniazid on vitamin D metabolism | Q34279202 | ||
Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy | Q34328579 | ||
High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial | Q34799320 | ||
Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania | Q35063882 | ||
Vitamin D₃supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trial | Q35113182 | ||
Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings | Q35154069 | ||
Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial | Q38442904 | ||
Vitamin D Deficiency in HIV-Infected Women on Antiretroviral Therapy Living in the Tropics | Q38951904 | ||
Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study | Q39019753 | ||
Ethnicity, Clothing Style, and Body Mass Index are Significant Predictors of Vitamin D Insufficiency in Germany | Q39116619 | ||
Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting | Q39591171 | ||
High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions? | Q39673591 | ||
Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients | Q40280595 | ||
Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients | Q41644519 | ||
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO). | Q42242966 | ||
Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients | Q42262759 | ||
Vitamin D deficiency in HIV-infected and -uninfected women in the United States | Q42939810 | ||
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. | Q43001305 | ||
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. | Q43048034 | ||
Do nevirapine and efavirenz affect vitamin D homeostasis similarly? | Q43584724 | ||
Body composition in HIV-infected women | Q43693522 | ||
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India | Q44007690 | ||
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. | Q44585706 | ||
P304 | page(s) | 1-8 | |
P577 | publication date | 2016-11-08 | |
P1433 | published in | British Journal of Nutrition | Q4970206 |
P1476 | title | Change in serum 25-hydroxyvitamin D with antiretroviral treatment initiation and nutritional intervention in HIV-positive adults |
Q99557494 | Statistical analysis of continuous outcomes from parallel-arm randomized controlled trials in nutrition-a tutorial | cites work | P2860 |
Search more.